Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

The government’s five‑year experiment could be the first step toward broad public coverage of GLP‑1 drugs. If a new experiment pans out, Medicaid and Medicare could begin covering the costly ...

According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

Thirty-nine percent of millennials and 35% of Gen Z say access to weight loss drugs would improve their job satisfaction or ...

Many pharmaceutical products made in Europe will face a 15 percent tariff, pinching manufacturers and potentially leading to ...